Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer
Folefac Aminkeng, Amit P. Bhavsar, Henk Visscher, et al.
Nature Genetics (2015) Vol. 47, Iss. 9, pp. 1079-1084
Open Access | Times Cited: 244

Showing 1-25 of 244 citing articles:

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
Alexander R. Lyon, Teresa López‐Fernández, Liam S. Couch, et al.
European Heart Journal (2022) Vol. 43, Iss. 41, pp. 4229-4361
Open Access | Times Cited: 1556
Human induced pluripotent stem cell–derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity
Paul W. Burridge, Yong Fuga Li, Elena Matsa, et al.
Nature Medicine (2016) Vol. 22, Iss. 5, pp. 547-556
Open Access | Times Cited: 649
Regulated cell death pathways in doxorubicin-induced cardiotoxicity
Effimia Christidi, Liam R. Brunham
Cell Death and Disease (2021) Vol. 12, Iss. 4
Open Access | Times Cited: 461
Cardio-Oncology
Carrie G. Lenneman, Douglas B. Sawyer
Circulation Research (2016) Vol. 118, Iss. 6, pp. 1008-1020
Closed Access | Times Cited: 377
Genome-wide association studies of cancer: current insights and future perspectives
Amit Sud, Ben Kinnersley, Richard S. Houlston
Nature reviews. Cancer (2017) Vol. 17, Iss. 11, pp. 692-704
Closed Access | Times Cited: 350
Cardiovascular Complications of Cancer Therapy
Hui‐Ming Chang, Rohit Moudgil, Tiziano M. Scarabelli, et al.
Journal of the American College of Cardiology (2017) Vol. 70, Iss. 20, pp. 2536-2551
Open Access | Times Cited: 340
Childhood cancer: Survival, treatment modalities, late effects and improvements over time
Friederike Erdmann, Line Elmerdahl Frederiksen, Audrey Bonaventure, et al.
Cancer Epidemiology (2020) Vol. 71, pp. 101733-101733
Open Access | Times Cited: 267
Novel Insights and Therapeutic Interventions for Pediatric Osteosarcoma
Leo Kager, Gevorg Tamamyan, Stefan Bielack
Future Oncology (2016) Vol. 13, Iss. 4, pp. 357-368
Closed Access | Times Cited: 215
Recommendations for genetic testing to reduce the incidence of anthracycline‐induced cardiotoxicity
Folefac Aminkeng, Colin J.D. Ross, Shahrad R. Rassekh, et al.
British Journal of Clinical Pharmacology (2016) Vol. 82, Iss. 3, pp. 683-695
Open Access | Times Cited: 210
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
Alexander R. Lyon, Teresa López‐Fernández, Liam S. Couch, et al.
European Heart Journal - Cardiovascular Imaging (2022) Vol. 23, Iss. 10, pp. e333-e465
Open Access | Times Cited: 210
Cardiovascular Disease in Survivors of Childhood Cancer: Insights Into Epidemiology, Pathophysiology, and Prevention
Saro H. Armenian, Gregory T. Armstrong, Gregory J. Aune, et al.
Journal of Clinical Oncology (2018) Vol. 36, Iss. 21, pp. 2135-2144
Open Access | Times Cited: 181
Systematic review and updated recommendations for cardiomyopathy surveillance for survivors of childhood, adolescent, and young adult cancer from the International Late Effects of Childhood Cancer Guideline Harmonization Group
Matthew J. Ehrhardt, Jan M. Leerink, Renée L. Mulder, et al.
The Lancet Oncology (2023) Vol. 24, Iss. 3, pp. e108-e120
Closed Access | Times Cited: 70
Modeling Doxorubicin-Induced Cardiotoxicity in Human Pluripotent Stem Cell Derived-Cardiomyocytes
A. Maillet, Kim Peng Tan, Xiaoran Chai, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 161
The Role of Biomarkers in Cardio-Oncology
Kajaluxy Ananthan, Alexander R. Lyon
Journal of Cardiovascular Translational Research (2020) Vol. 13, Iss. 3, pp. 431-450
Open Access | Times Cited: 133
Predicting and Preventing Anthracycline-Related Cardiotoxicity
Saro H. Armenian, Smita Bhatia
American Society of Clinical Oncology Educational Book (2018), Iss. 38, pp. 3-12
Closed Access | Times Cited: 124
Novel genetic and epigenetic factors of importance for inter-individual differences in drug disposition, response and toxicity
Volker M. Lauschke, Yitian Zhou, Magnus Ingelman‐Sundberg
Pharmacology & Therapeutics (2019) Vol. 197, pp. 122-152
Open Access | Times Cited: 113
Determining the genetic basis of anthracycline-cardiotoxicity by molecular response QTL mapping in induced cardiomyocytes
David A. Knowles, Courtney K. Burrows, John Blischak, et al.
eLife (2018) Vol. 7
Open Access | Times Cited: 107
Paediatric cardio-oncology: epidemiology, screening, prevention, and treatment
Eric J. Chow, Kasey J. Leger, Neel S. Bhatt, et al.
Cardiovascular Research (2019) Vol. 115, Iss. 5, pp. 922-934
Open Access | Times Cited: 101
The role of pharmacogenomics in adverse drug reactions
Ramón Cacabelos, Natalia Cacabelos, Juan C. Carril
Expert Review of Clinical Pharmacology (2019) Vol. 12, Iss. 5, pp. 407-442
Closed Access | Times Cited: 98
Complex roads from genotype to phenotype in dilated cardiomyopathy: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology
Antoine Bondue, Eloisa Arbustini, Anna Monica Bianco, et al.
Cardiovascular Research (2018) Vol. 114, Iss. 10, pp. 1287-1303
Open Access | Times Cited: 94
Candidate Gene Association Studies of Anthracycline-induced Cardiotoxicity: A Systematic Review and Meta-analysis
Siew Lian Leong, Nathorn Chaiyakunapruk, Shaun Wen Huey Lee
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 92
Genome-Wide Association Study for Anthracycline-Induced Congestive Heart Failure
Bryan P. Schneider, Fei Shen, Laura Gardner, et al.
Clinical Cancer Research (2016) Vol. 23, Iss. 1, pp. 43-51
Open Access | Times Cited: 88
Priorities in Cardio-Oncology Basic and Translational Science
Fadi N. Salloum, Carlo G. Tocchetti, Pietro Ameri, et al.
JACC CardioOncology (2023) Vol. 5, Iss. 6, pp. 715-731
Open Access | Times Cited: 23
Functional Validation of Doxorubicin-Induced Cardiotoxicity-Related Genes
Hananeh Fonoudi, Mariam Jouni, Romina B. Cejas, et al.
JACC CardioOncology (2024) Vol. 6, Iss. 1, pp. 38-50
Open Access | Times Cited: 14
Molecular Mechanisms of Cardiotoxicity: A Review on Major Side-effect of Doxorubicin
Michael Mobaraki, Abolfazl Faraji, Masoud Zare, et al.
Indian Journal of Pharmaceutical Sciences (2017) Vol. 79, Iss. 3
Open Access | Times Cited: 83
Page 1 - Next Page

Scroll to top